About Index Trending news
Analyze
Top 50 Pricing
Cellartis

Cellartis

Work at Cellartis? Add yourself to this profile

Cellartis

Cellartis develops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital
$9,540,000
Employees

Unknown size

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Cellartis makes some noise.